Action FutureTech II Acquisition - FTII

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Dernier

11,95

Prix Achat

10,62

Prix Vente

12,48

Volume échangé

11,93 Fourchette du Jour 11,93

10,85 Plage de 52 semaines 12,48

Cap du marché

35,306M

Clôture Veille

11,95

Ouverture

11,93

Dernière Transaction

11.16

Dernière heure de transaction

Volume financier

VWAP

Volume moyen (3 m)

11 520

Actions en circulation

2 954 510

Rendement du Dividende

Ratio Cours sur Bénéfices

12,12

Bénéfice par action (BPA)

0,99

Chiffre d'affairess

Bénéfice net

2,91M

FutureTech II Acquisition Corp is a blank check company. FutureTech II Acquisition Corp is a blank check company.

Secteur

Blank Checks

Industrie

Blank Checks

Siège social

Wilmington, Delaware, USA

Fondé

FutureTech II Acquisition Corporation est coté dans le secteur Blank Checks de la NASDAQ avec le ticker FTII. Le dernier cours de clôture d'FutureTech II Acquisition était de US$11,95. Au cours de la dernière année, les actions de FutureTech II Acquisition ont été négociées dans une fourchette de prix de US$ 10,85 à US$ 12,48.

FutureTech II Acquisition compte actuellement 2 954 510 actions en circulation. La capitalisation boursière d'FutureTech II Acquisition est de US$35,31 million. FutureTech II Acquisition a un ratio cours/bénéfice (ratio PE) de 12.12.

FutureTech II Acquisition Corp. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Reports on Form 10-Q and Publicly Held Shares Rule and Makes Progress Towards Regaining Compliance

New York, New York, Dec. 04, 2024 (GLOBE NEWSWIRE) -- FutureTech II Acquisition Corp. (the “Company”) (NASDAQ: FTII), today announced that it received an expected deficiency notification letter...

Longevity Biomedical, Inc. and FutureTech II Acquisition Corp. Announce Business Combination to Create Nasdaq-Listed Biopharmaceutical Company Focused on Advancing New Technologies to Promote Human Health and Longevity

-Longevity Biomedical, Inc. is focused on developing and acquiring new technologies spanning therapeutics, health monitoring and digital health solutions to become a leading provider of...

FutureTech II Acquisition Corp. Confirms Funding and Extension of Period to Complete Initial Business Combination

New Rochelle, NY, May 17, 2023 (GLOBE NEWSWIRE) -- FutureTech II Acquisition Corp. (Nasdaq: FTIIU) (the “Company”), a blank check company formed for the purpose of effecting a merger, capital...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	-0.04	-0.333611342786	11.99	12.24	11.16	443	11.76012415	CS
4	0.84	7.56075607561	11.11	12.3	11	1471	11.39967743	CS
12	0.74	6.60124888492	11.21	12.48	10.85	11520	11.11969519	CS
26	0.91	8.24275362319	11.04	12.48	10.85	7177	11.11140955	CS
52	1.05	9.63302752294	10.9	12.48	10.85	13737	11.06594751	CS
156	2	20.1005025126	9.95	12.48	9.95	24494	10.5272841	CS
260	2	20.1005025126	9.95	12.48	9.95	24494	10.5272841	CS

FTII - Frequently Asked Questions (FAQ)

What is the current FutureTech II Acquisition share price?

The current share price of FutureTech II Acquisition is US$ 11,95

How many FutureTech II Acquisition shares are in issue?

FutureTech II Acquisition has 2 954 510 shares in issue

What is the market cap of FutureTech II Acquisition?

The market capitalisation of FutureTech II Acquisition is USD 35,31M

What is the 1 year trading range for FutureTech II Acquisition share price?

FutureTech II Acquisition has traded in the range of US$ 10,85 to US$ 12,48 during the past year

What is the PE ratio of FutureTech II Acquisition?

The price to earnings ratio of FutureTech II Acquisition is 12,12

What is the reporting currency for FutureTech II Acquisition?

FutureTech II Acquisition reports financial results in USD

What is the latest annual profit for FutureTech II Acquisition?

The latest annual profit of FutureTech II Acquisition is USD 2,91M

What is the registered address of FutureTech II Acquisition?

The registered address for FutureTech II Acquisition is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

Which industry sector does FutureTech II Acquisition operate in?

FutureTech II Acquisition operates in the BLANK CHECKS sector

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
DATSDatChat Inc	US$ 8,82 (350,00%)	204,79M
HOTHHoth Therapeutics Inc	US$ 2,22 (170,86%)	415,2M
DRIODarioHealth Corporation	US$ 1,5479 (81,68%)	2,48M
SVMHSRIVARU Holding Ltd	US$ 0,0829 (79,05%)	1,38B
SPISPI Energy Company Ltd	US$ 0,6755 (57,09%)	136,4M
DHAIDIH Holdings US Inc	US$ 1,7899 (-38,70%)	1,52M
CISOCISO Global Inc	US$ 1,70 (-37,04%)	692,1k
SLRNACELYRIN Inc	US$ 2,21 (-36,68%)	11,57M
BOXLBoxlight Corporation	US$ 1,16 (-30,95%)	6,54M
AMSTAmesite Inc	US$ 2,80 (-30,86%)	943,11k
XTIAXTI Aerospace Inc	US$ 0,1141 (29,66%)	2,67B
SVMHSRIVARU Holding Ltd	US$ 0,0829 (79,05%)	1,39B
CEROCERo Therapeutics Holdings Inc	US$ 0,0515 (21,75%)	901,67M
RIMEAlgorhythm Holdings Inc	US$ 0,22647 (56,40%)	672,88M
HOTHHoth Therapeutics Inc	US$ 2,22 (170,86%)	417,91M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

FutureTech II Acquisition Corporation (FTII)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

À propos de FutureTech II Acquisition Corporation

FTII Dernières nouvelles

FutureTech II Acquisition Corp. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Reports on Form 10-Q and Publicly Held Shares Rule and Makes Progress Towards Regaining Compliance

Longevity Biomedical, Inc. and FutureTech II Acquisition Corp. Announce Business Combination to Create Nasdaq-Listed Biopharmaceutical Company Focused on Advancing New Technologies to Promote Human Health and Longevity

FutureTech II Acquisition Corp. Confirms Funding and Extension of Period to Complete Initial Business Combination

FutureTech II Acquisition Corp. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Reports on Form 10-Q and Publicly Held Shares Rule and Makes Progress Towards Regaining Compliance

Longevity Biomedical, Inc. and FutureTech II Acquisition Corp. Announce Business Combination to Create Nasdaq-Listed Biopharmaceutical Company Focused on Advancing New Technologies to Promote Human Health and Longevity

FTII - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

FutureTech II Acquisition Corporation (FTII) Cours

FutureTech II Acquisition Corporation (FTII)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

À propos de FutureTech II Acquisition Corporation

FTII Dernières nouvelles

FutureTech II Acquisition Corp. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Reports on Form 10-Q and Publicly Held Shares Rule and Makes Progress Towards Regaining Compliance

Longevity Biomedical, Inc. and FutureTech II Acquisition Corp. Announce Business Combination to Create Nasdaq-Listed Biopharmaceutical Company Focused on Advancing New Technologies to Promote Human Health and Longevity

FutureTech II Acquisition Corp. Confirms Funding and Extension of Period to Complete Initial Business Combination

FutureTech II Acquisition Corp. Receives Notification of Deficiency from Nasdaq Related to Delayed Filing of Quarterly Reports on Form 10-Q and Publicly Held Shares Rule and Makes Progress Towards Regaining Compliance

Longevity Biomedical, Inc. and FutureTech II Acquisition Corp. Announce Business Combination to Create Nasdaq-Listed Biopharmaceutical Company Focused on Advancing New Technologies to Promote Human Health and Longevity

FTII - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application